AT266822B - Verfahren zur Herstellung neuer Indolderivate und ihrer Salze - Google Patents
Verfahren zur Herstellung neuer Indolderivate und ihrer SalzeInfo
- Publication number
- AT266822B AT266822B AT206067A AT206067A AT266822B AT 266822 B AT266822 B AT 266822B AT 206067 A AT206067 A AT 206067A AT 206067 A AT206067 A AT 206067A AT 266822 B AT266822 B AT 266822B
- Authority
- AT
- Austria
- Prior art keywords
- salts
- production
- indole derivatives
- new indole
- new
- Prior art date
Links
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH898666A CH469002A (de) | 1966-06-21 | 1966-06-21 | Verfahren zur Herstellung neuer Indolderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT266822B true AT266822B (de) | 1968-12-10 |
Family
ID=4347068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT206067A AT266822B (de) | 1966-06-21 | 1967-03-03 | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | AT266822B (de) |
| CH (1) | CH469002A (de) |
| CS (1) | CS156407B2 (de) |
| DK (1) | DK124612B (de) |
| ES (1) | ES337458A1 (de) |
| FI (1) | FI47366C (de) |
| SE (1) | SE308110B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980000152A1 (fr) * | 1978-07-03 | 1980-02-07 | Sandoz Ag | Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation |
| EP0013878A1 (de) * | 1979-01-18 | 1980-08-06 | Sandoz Ag | 3-Aminopropoxyaryl-Derivate, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| PL375713A1 (en) | 2002-08-19 | 2005-12-12 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
| GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| EP2094643B1 (de) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf-erkrankungen |
| US9782488B2 (en) | 2007-03-12 | 2017-10-10 | Nektar Therapeutics | Oligomer-beta blocker conjugates |
| EP2986599A1 (de) | 2013-04-17 | 2016-02-24 | Pfizer Inc. | N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| CR20210441A (es) | 2019-01-18 | 2022-03-11 | Astrazeneca Ab | Inhibidores de la pcsk9 y métodos de uso de los mismos |
-
1966
- 1966-06-21 CH CH898666A patent/CH469002A/de unknown
-
1967
- 1967-03-02 CS CS155767A patent/CS156407B2/cs unknown
- 1967-03-02 ES ES337458A patent/ES337458A1/es not_active Expired
- 1967-03-02 FI FI670617A patent/FI47366C/fi active
- 1967-03-03 AT AT206067A patent/AT266822B/de active
- 1967-03-03 SE SE2931/67A patent/SE308110B/xx unknown
- 1967-03-03 DK DK112967AA patent/DK124612B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH469002A (de) | 1969-02-28 |
| FI47366B (de) | 1973-07-31 |
| SE308110B (de) | 1969-02-03 |
| DK124612B (da) | 1972-11-06 |
| ES337458A1 (es) | 1968-03-01 |
| FI47366C (fi) | 1973-11-12 |
| CS156407B2 (de) | 1974-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT291249B (de) | Verfahren zur Herstellung neuer Imidazolderivate und ihrer Salze | |
| AT286978B (de) | Verfahren zur herstellung neuer heterocyclischer aminoverbindungen und ihrer salze | |
| AT317885B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| AT266822B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| AT266112B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| AT278838B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate und ihrer Salze | |
| AT266839B (de) | Verfahren zur Herstellung neuer basischer Derivate des Dibenzoxepins und deren Salzen | |
| AT279636B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate | |
| AT276387B (de) | Verfahren zur Herstellung neuer Pyrazolderivate und ihrer Salze | |
| AT291989B (de) | Verfahren zur Herstellung neuer Nitroimidazolderivate und ihrer Salze | |
| AT289095B (de) | Verfahren zur Herstellung neuer Succinimidderivate und ihrer Salze | |
| AT267513B (de) | Verfahren zur Herstellung neuer 1-Arylpyrrolidinderivate und ihrer Salze | |
| AT286979B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| CH475981A (de) | Verfahren zur Herstellung neuer Indol-Derivate | |
| AT278022B (de) | Verfahren zur Herstellung neuer Diphenyl-pyridazone und ihrer Salze | |
| AT315830B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| AT293414B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate und ihrer Salze | |
| AT256097B (de) | Verfahren zur Herstellung neuer Indolderivate | |
| AT269132B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| AT272335B (de) | Verfahren zur Herstellung neuer 1,2,3,4-Tetrahydrocarbazolderivate und ihrer Salze | |
| AT262302B (de) | Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate und ihrer Salze | |
| AT290527B (de) | Verfahren zur Herstellung neuer Bisimidazolyl-bisphenylmethane und ihrer Salze | |
| AT269870B (de) | Verfahren zur Herstellung neuer Indolderivate und ihrer Salze | |
| AT273102B (de) | Verfahren zur Herstellung neuer 1-Aryl-imidazole und ihrer Salze | |
| AT269124B (de) | Verfahren zur Herstellung neuer Tetrahydrofuranderivate und ihrer Salze |